Authors
Latest:
Q&A: Late-Breaking REMIX-1 and REMIX-2 Data Demonstrated Efficacy of Remibrutinib in Chronic Spontaneous UrticariaAllergist immunologist Giselle Mosnaim, MD, recently spoke with Dermatology Times to discuss late-breaking phase 3 REMIX-1 and REMIX-2 data presented at the American Academy of Allergy, Asthma, and Immunology Annual Meeting.
Latest:
In Skin Cancer, Immunotherapy May Lead to Chronic EffectsResearch showed that many patients with skin cancer who had been treated using immunotherapy, such as immune checkpoint inhibition, experienced chronic side effects.
Latest:
Denise Dajles, DEng, MSc, Ushers in a New Era at Cytrellis Biosystems, Looks to Future of Aesthetics IndustryCytrellis' new president and CEO discusses bridging surgery and innovation in aesthetics.
Latest:
Insight from Anant Madabhushi, PhD on AI in Dermatologic CareHis keynote speech at ACMS focused on artificial intelligence for precision medicine and cancer diagnosis.
Latest:
Measuring Atopic Dermatitis Treatment SuccessGina Mangin, MPAS, PA-C, discusses how measuring atopic dermatitis treatment success requires evaluating multiple factors, including reduction in itch intensity, improvement in sleep quality, decreased flare frequency, enhanced quality of life, and visible skin healing through standardized assessment tools and patient-reported outcomes.
Latest:
Vitiligo Case Report: A 9-Year Old Patient With White Macules, Halo NevusJordan Bui and Bernard A. Cohen, MD, review a case of a young patient with vitiligo.
Latest:
Phase 3 Ruxolitinib Study Shows Higher Rates of Adolescent RepigmentationDavid Rosmarin, MD, shared his insights on the study in a Q&A with Dermatology Times.
Latest:
Turn Therapeutics' Atopic Dermatitis Candidate Achieves 57% Reduction in Disease Severity in 7 DaysBradley Burnam discusses results from an in-vivo model of atopic dermatitis.
Latest:
Test Your Knowledge: OncodermatologyEarlier this summer, Meghan Heberton, MD, emphasized the importance and growth of the subspecialty.
Latest:
James Del Rosso, DO, on What’s New in the Medicine ChestIn his presentation at Winter Clinical Miami, Del Rosso covered new and emerging therapies as well as successful off-label uses.
Latest:
Rad Quotes From RAD 2023Experts in the field share why they enjoyed the 5th Annual Revolutionizing Atopic Dermatitis Conference and why it is unique.
Latest:
“My Skin My Story” Provides Creative Outlet for Young Patients With EczemaJohn Browning, MD, FAAD, FAAP, MBA, discusses the new online platform that allows young patients to share their skin journey with others.
Latest:
Quality of Life + Closing ThoughtsMickey Bryson describes the impact of atopic dermatitis on his quality of life and family, and the session concludes with final reflections.
Latest:
Pharmacists Play Crucial Role in Advising Patients With Androgenetic AlopeciaPharmacists play a role in advising patients with hair loss about self-management and proper application of over the counter products.
Latest:
We are Biologic Coordinators of Dermatology (BCoD)Explore how BCs are supported through complex drug approvals and ensuring patients have access to prescribed medications.
Latest:
Expanding Laser Benefits for Diverse Patient PopulationsA panelist discusses how laser treatments have evolved to effectively address diverse skin conditions and aesthetic concerns across different ethnicities, expanding access to personalized care options.
Latest:
Overview of Prurigo Nodularis for Practicing Dermatology CliniciansIt is crucial to better understand, diagnose, and manage this skin condition associated with significant quality-of-life impairment.
Latest:
Dermatologic differences in a diverse populationUnderstanding the difference in biology and clinical presentations of cutaneous conditions in different skin types is critical for health care professionals to treat a diverse population.
Latest:
OX40-Ligand: A Conductor of the Atopic Dermatitis Inflammatory Symphony?Given the complexity of the underlying inflammation in patients with AD, an increased understanding of the OX40L pathway can improve our understanding of AD pathogenesis.
Latest:
“ARM Yourself with Knowledge": Emmy Graber, MD, MBA, Shares Insights on Acne, Rosacea, and MoreGraber spoke with Dermatology Times to share the top clinical pearls and key takeaways from the recent meetings.
Latest:
Utilizing Multidisciplinary Solutions for ItchSonya Kenkare, MD, explains her approach to itch and the support system of multiple specialties to help a pediatric patient with atopic dermatitis.
